Aurora Cannabis Inc. (ACB.TO)
CAD 6.11
(-4.83%)
CAD 6.11
(-4.83%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 838.67 Million CAD | -9.46% |
| 2022 | 926.32 Million CAD | -14.57% |
| 2021 | 1.08 Billion CAD | -58.37% |
| 2020 | 2.6 Billion CAD | -6.43% |
| 2019 | 2.78 Billion CAD | -49.41% |
| 2018 | 5.5 Billion CAD | 188.0% |
| 2017 | 1.91 Billion CAD | 492.14% |
| 2016 | 322.67 Million CAD | 1654.02% |
| 2015 | 18.39 Million CAD | 36.0% |
| 2014 | 13.52 Million CAD | 616.7% |
| 2013 | 1.88 Million CAD | 162.66% |
| 2012 | 718.54 Thousand CAD | -35.91% |
| 2011 | 1.12 Million CAD | -19.22% |
| 2010 | 1.38 Million CAD | -19.74% |
| 2009 | 1.72 Million CAD | 6.27% |
| 2008 | 1.62 Million CAD | -3.81% |
| 2007 | 1.69 Million CAD | 280.13% |
| 2006 | 445.06 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 818.37 Million CAD | -1.66% |
| 2023 Q2 | 817.16 Million CAD | -0.15% |
| 2023 Q3 | 838.67 Million CAD | 2.63% |
| 2023 FY | 838.67 Million CAD | -9.46% |
| 2022 Q4 | 832.18 Million CAD | -10.16% |
| 2022 Q2 | 1.02 Billion CAD | -12.49% |
| 2022 FY | 926.32 Million CAD | -14.57% |
| 2022 Q3 | 926.32 Million CAD | -9.52% |
| 2022 Q1 | 1.16 Billion CAD | 7.89% |
| 2021 Q2 | 2.48 Billion CAD | -2.93% |
| 2021 Q1 | 2.56 Billion CAD | -1.71% |
| 2021 FY | 1.08 Billion CAD | -58.37% |
| 2021 Q4 | 1.08 Billion CAD | -30.94% |
| 2021 Q3 | 1.57 Billion CAD | -36.82% |
| 2020 Q2 | 2.83 Billion CAD | 2.64% |
| 2020 FY | 2.6 Billion CAD | -6.43% |
| 2020 Q4 | 2.6 Billion CAD | -8.13% |
| 2020 Q3 | 2.83 Billion CAD | 0.18% |
| 2020 Q1 | 2.75 Billion CAD | -0.95% |
| 2019 FY | 2.78 Billion CAD | -49.41% |
| 2019 Q2 | 4.67 Billion CAD | -16.67% |
| 2019 Q1 | 5.6 Billion CAD | 1.89% |
| 2019 Q3 | 4.71 Billion CAD | 0.98% |
| 2019 Q4 | 2.78 Billion CAD | -40.99% |
| 2018 Q3 | 5.54 Billion CAD | 13.82% |
| 2018 Q1 | 4.95 Billion CAD | 159.35% |
| 2018 FY | 5.5 Billion CAD | 188.0% |
| 2018 Q2 | 4.87 Billion CAD | -1.6% |
| 2018 Q4 | 5.5 Billion CAD | -0.85% |
| 2017 Q4 | 1.91 Billion CAD | 14.32% |
| 2017 FY | 1.91 Billion CAD | 492.14% |
| 2017 Q3 | 1.67 Billion CAD | 128.21% |
| 2017 Q2 | 732.39 Million CAD | 110.56% |
| 2017 Q1 | 347.83 Million CAD | 7.8% |
| 2016 Q4 | 322.67 Million CAD | 63.74% |
| 2016 Q1 | 56.76 Million CAD | 208.58% |
| 2016 Q2 | 98.21 Million CAD | 73.02% |
| 2016 Q3 | 197.06 Million CAD | 100.64% |
| 2016 FY | 322.67 Million CAD | 1654.02% |
| 2015 Q2 | 16.76 Million CAD | 20.61% |
| 2015 Q1 | 13.89 Million CAD | 2.74% |
| 2015 FY | 18.39 Million CAD | 36.0% |
| 2015 Q4 | 18.39 Million CAD | -17.58% |
| 2015 Q3 | 22.31 Million CAD | 33.17% |
| 2014 Q2 | 9.76 Million CAD | 93.77% |
| 2014 FY | 13.52 Million CAD | 616.7% |
| 2014 Q4 | 13.52 Million CAD | 32.94% |
| 2014 Q3 | 10.17 Million CAD | 4.18% |
| 2014 Q1 | 5.04 Million CAD | 167.05% |
| 2013 Q4 | 1.88 Million CAD | 223.9% |
| 2013 FY | 1.88 Million CAD | 162.66% |
| 2013 Q3 | 582.69 Thousand CAD | -7.18% |
| 2013 Q2 | 627.78 Thousand CAD | -5.92% |
| 2013 Q1 | 667.31 Thousand CAD | -7.13% |
| 2012 Q3 | 810.71 Thousand CAD | -7.94% |
| 2012 Q2 | 880.68 Thousand CAD | -12.19% |
| 2012 Q1 | 1 Million CAD | -10.55% |
| 2012 FY | 718.54 Thousand CAD | -35.91% |
| 2012 Q4 | 718.54 Thousand CAD | -11.37% |
| 2011 Q4 | 1.12 Million CAD | -12.41% |
| 2011 Q3 | 1.28 Million CAD | -2.15% |
| 2011 Q2 | 1.3 Million CAD | -3.06% |
| 2011 Q1 | 1.34 Million CAD | -2.78% |
| 2011 FY | 1.12 Million CAD | -19.22% |
| 2010 Q1 | 1.69 Million CAD | -2.12% |
| 2010 Q3 | 1.41 Million CAD | -13.63% |
| 2010 Q4 | 1.38 Million CAD | -2.14% |
| 2010 FY | 1.38 Million CAD | -19.74% |
| 2010 Q2 | 1.64 Million CAD | -2.99% |
| 2009 FY | 1.72 Million CAD | 6.27% |
| 2009 Q3 | 1.65 Million CAD | -5.45% |
| 2009 Q1 | 1.61 Million CAD | -0.91% |
| 2009 Q2 | 1.75 Million CAD | 8.84% |
| 2009 Q4 | 1.72 Million CAD | 4.22% |
| 2008 Q2 | 1.65 Million CAD | -1.69% |
| 2008 Q4 | 1.62 Million CAD | -0.59% |
| 2008 FY | 1.62 Million CAD | -3.81% |
| 2008 Q1 | 1.68 Million CAD | -0.21% |
| 2008 Q3 | 1.63 Million CAD | -1.37% |
| 2007 Q2 | 1.71 Million CAD | 286.36% |
| 2007 Q1 | 443 Thousand CAD | 0.0% |
| 2007 FY | 1.69 Million CAD | 280.13% |
| 2007 Q4 | 1.69 Million CAD | -1.21% |
| 2007 Q3 | 1.71 Million CAD | 0.06% |
| 2006 FY | 445.06 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avicanna Inc. | 21.97 Million CAD | -3717.163% |
| Avant Brands Inc. | 82.55 Million CAD | -915.933% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -2185.181% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -3309.517% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 11.298% |
| MediPharm Labs Corp. | 63.93 Million CAD | -1211.718% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | -181.005% |
| Canopy Growth Corporation | 1.3 Billion CAD | 35.503% |
| Willow Biosciences Inc. | 6.67 Million CAD | -12468.155% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | -220.222% |